NovaBay Pharmaceuticals, Inc. (NBY) has a market capitalization of $50.06M and trades at $1.88. The 52-week range is 1.11-99.75.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.5, Earnings Per Share (EPS) of $-3.80.
The stock has a beta of 0.16, a last dividend of $0.8000, operates in the Healthcare sector.
